بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.

Slides:



Advertisements
Similar presentations
Diffusion-Weighted Imaging in Magnetic Resonance Imaging for prostate gland in Malaysian males with high prostate specific antigen in the diagnosis of.
Advertisements

Marion Swall, MIV USC School of Medicine. Epidemiology Prostate cancer is the most common cancer & #2 cancer killer in American men Approx 190,000 cases.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Imaging modalities in prostate cancer
MODULE 5 1/33 Case 5: Sam. MODULE 5 Case 5: Sam 2/33 Patient History  Sam is a 66 year old retired painter & construction worker.  He is distressed.
MODULE 5 1/40 Case 3: Chuck. MODULE 5 Case 3: Chuck 2/40 Patient History  Chuck is a 66 year old retired chemical compounder  He is distressed by the.
THE CLINICO-PATHOLOGIC PATTERNS OF PROSTATIC DISEASES AND PROSTATE CANCER IN SAUDI PATIENTS Hisham A. M. Mosli, FRCSC, FACS Taha A. Abdel-Meguid, MD Jaudah.
CA of Prostate:Incidence In a 50 y/o man In a 50 y/o man In autopsy: 40% In autopsy: 40% Clinical: 10% Clinical: 10% Death: 3% Death: 3% Most common non-cutanous.
Prostate Pathophysiology Charles L. Hitchcock, MD PhD Associate Professor - Clinical Department of Pathology.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Benign Prostatic Hyperplasia Dr.Bandar Al Hubaishy Urology Department KAUH.
In The Nam of God.
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
Prostate Cancer Treatments By: Ishan Parikh. Symptoms Be on the look out for… “stop-and-go” flow of urine Sudden urges to urinate Frequent urination (esp.
Steven Joniau Filip Ameye
Prostate Cancer Education Seminar. What is the Prostate? A male sex gland The size of a walnut below the bladder and in front of the rectum Produces the.
Everything you need to know about Prostate Radiotherapy During the talk or at end send QUESTIONS: Rob.
Understanding the Importance of Prostate Health Middle aged men
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99 mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT,
Prostate Cancer By: Kurt Rishel.
RISK OF NON SIGNIFICANT PROSTATE CANCER IN PROSTATE CANCER PATIENTS DIAGNOSED BY AN EXTENDED PROSTATE NEEDLE BIOPSY PROCEDURE AND TREATED BY RADICAL PROSTATECTOMY.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Benign Prostatic Hyperplasia
Urology Update Sanofi- Aventis
Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.
Mark L. Merlin, M.D. Radiotherapy Clinics of Georgia 7/14/2010 The Role of Radiation Therapy in the Management of Prostate Cancer.
Carcinoma of prostate 1. Incidence ❏ most prevalent cancer in males ❏ second leading cause of male cancer deaths ❏ lifetime risk of a 50 years man for.
Prostate Pathology Emad Raddaoui, MD, FCAP, FASC.
CASE 1 65-year-old man No other diseases or previous surgeries July 2005: PSA 11.5 ng/ml; F/T: 9% After prostate biopsy revealing adenocarcinoma: RETROPUBIC.
Genitourinary Imaging-----Prostate
Figure 1. Gross specimen of prostate gland.. Figure 2. Microscopic effects of BPH.
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
“Prostate Cartography”: Targeted &systematic perineal stereotactic prostate biopsy using the BiopSee®platform in locating and re-locating prostate cancer.
Prostate Pathology. Prostate weighs 20 grams in normal adult Retroperitoneal organ,encircling the neck of bladder and urethra Devoid of a distinct capsule.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
Prostate Dr. Amitabha Basu MD.
TNM Staging: Prostate TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
1 Prostate Cancer. 2 Prostate Gland Muscular Walnut-sized gland Makes seminal fluid Muscles contract to push semen through the urethra Located directly.
Genitourinary Blueprint
Prostate Dr. Atif Ali Bashir MD. Prostate Pathology ► Prostate weighs 20 grams in normal adult ► Retroperitoneal organ,encircling the neck of bladder.
Gian Maria Busetto Sapienza Rome University Prostate cancer gene 3 (PCA3) and multiparametric magnetic resonance (mMRI) can reduce unnecessary biopsies:
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Department of Urology, Guangzhou First Municipal People’s Hospital, Guangzhou Medical College, Guangzhou, China Rubiao Ou, Meng You, Ping Tang, Hui Chen,
Reference: Robbins & Cotran Pathology and Rubin’s Pathology
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
SON 2112 Ultrasound of the Abdomen Part II
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.
Prostate Pathology Sufia Husain. Pathology Department KSU, Riyadh
Prostate Pathology Sufia Husain. Pathology Department KSU, Riyadh
Carcinoma of the prostate
Reference: Robbins & Cotran Pathology and Rubin’s Pathology
Prostate cancer นพ.ชัชชัย หอมเกตุ.
Prostate Cancer Dr .Gehan Mohamed.
Nat. Rev. Urol. doi: /nrurol
#96 Roles Of Urodynamics In the Assessment of Post Radical
SON 2112 Ultrasound of the Abdomen Part II
Fig. 1c: Cystoprostatectomy specimen
CONVERSATIONS ON PROSTATE CANCER
Apollo Gleneagles Hospitals,
Volume 54, Issue 3, Pages (September 2008)
Volume 72, Issue 3, Pages (September 2017)
Evaluation and Medical Management of Benign Prostatic Hyperplasia
Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI- RADS v2) scoring system in diagnosis of peripheral zone prostate cancer 
Prostate-Specific Antigen, Digital Rectal Examination, and Transrectal Ultrasonography: Their Roles in Diagnosing Early Prostate Cancer  MICHAEL R. CUPP,
Volume 54, Issue 6, Pages (December 2008)
Prostate Cancer Update
Presentation transcript:

بسم الله الرحمن الرحيم

The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation

Introduction

The ability to differentiate between carcinoma confined to the prostate and the extracapsular spread of tumor is the key point for management. ( Enlund et al 1990) Radical prostatectomy is performed for carcinoma localized to the prostate but if the tumor extends beyond the prostatic capsule,other treatment options like radiotherapy ( external beam irradiation or Brachytherapy ),Hormonal therapy will be tried ( Boccon et al 2003).

Previous studies predict extracapular spread of tumor through elevated serum PSA > 10 ng/ml,increased number of positive cores in guided biopsies which means increased tumor volume, detection of perineural invasion in biopsy samples and Gleason score =7 or more ( Tarjan et al 2006)

ECE of prostate cancer can lead to failure of radical prostatectomy and every attempt should be made to localize the tumor and assess its extensions preoperatively. It is very disappointing to inform the patient that he has recurrent cancer or the cancer will recur after he performed radical prostatectomy and after he was exposed to all operative and post operative risks including impotence and urinary incontinence

Our current study is an attempt to localize the prostate cancer and to assess its local extensions prior to surgery using transrectal ultrasound assisted with power Doppler and 3D capabilities in addition to TRUS guided biopsy and to distinguish malignant from common prostatic pathologies like inflammation and BPH

The aim of the work:- To evaluate the value of three dimensional (3D), two dimensional (2D) as well as power Doppler transrectal ultrasound (TRUS) in the diagnosis of different prostatic lesions and in the assessment of local extensions of prostatic cancer

Patients and Methods

2-D TRUS, power Doppler sonography and 3D TRUS were performed for 100 patients. All patients were complaining of lower urinary tract obstructive or irritative symptoms or they had abnormal digital rectal examination (DRE) and or they had elevated serum prostatic specific antigen (PSA) level.

Biopsies were performed for 77 cases showing suspicious areas within the prostate during 2-D,3-D TRUS, abnormal flow pattern with power Doppler sonography and for cases with abnormal DRE or elevated serum total PSA >4 ng/ml or when the percent- free PSA is 10% or less after taking patient consent. The patients were instructed to take antibiotics before and after the procedure, to stop any anticoagulants or nonsteroidal anti-inflammatory drugs and to do an enema before the procedure.

Eight tissue samples were taken from different prostatic regions (6 tissue samples were taken from the midlobe parasagittal planes bilaterally at the base, middle and apical prostatic zones and 2 samples from the lateral aspect of each lobe) in addition, targeted tissue samples were taken from the suspicious focal lesions or from the seminal vesicles suspected tumor infiltration observed during transrectal ultrasound. TRUS and TRUS guided biopsy were performed in an outpatient setting.

In cancer patients, the final diagnosis was reached based on the result of true cut prostatic biopsies, target biopsies of the region of interest, post radical prostatectomy pathological reports, cystoscopy and biopsy of urinary bladder in cases of suspected urinary bladder infiltration, targeted seminal vesicle biopsy in cases with suspected infiltration and post radical prostatectomy pathological reports

In patients with BPH, estimation of adenomata volume with 2-D and 3-D TRUS was compared with the estimated adenoma volume after transurethral resection of prostate or open prostatectomy. An estimated% error in the volume calculation of adenoma using 2-D and 3-D TRUS was calculated by dividing the difference between the estimated 2-D or 3-D ultrasound volume and the estimated postoperative volume of adenoma/postoperative volume of adenoma.

Results

. 2-D Transrectal US aided with power Doppler and 3-D TRUS were performed for 100 patients, the final diagnosis was reached in 77 patients. Eighteen patients showed prostatic carcinomas, one patient showed prostatic sarcoma. 38 patients showed benign prostatic hyperplasia (BPH). Twenty patients diagnosed as prostatitis.

In patients with biopsy proved prostatic cancer 3-D TRUS showed estimated sensitivity 78.9% and specificity 94.8% with total accuracy 90.9% with respect to an estimated sensitivity 63.1%, specificity 86.2% and total accuracy 80.5% with 2-D TRUS

3-D TRUS clearly identifies the extraprostatic spread to the periprostatic fat at 3 out of 3 patients, infiltration to the seminal vesicles in 3 out of 3 patients, infiltration of the base of urinary bladder in 2 out of 2 patients and also the presence of capsular breaks in 4 patients out of 5.

The results were equivocal or negative in 3 patients by 2D ultrasonography for detecting intra glandular lesions and were negative in detecting capsular breaks in 3 patients out of 5 proved by biopsy but it was able to detect all patients with infiltration to the periprostatic fat planes and the base of urinary bladder and in 2 patients out of 3 with seminal vesicles infiltration. Both techniques failed to diagnose 2 patients with biopsy proved transitional zone carcinoma and 2 patients with localized intra glandular peripheral zone lesions, possibly due to the isoechoic nature of the lesions in the later.

In patients with benign prostatic hyperplasia (BPH), the postoperative data after transurethral resection of prostatic adenomas or open prostatectomy received and compared with 2-D and 3-D TRUS results showed that 3-D TRUS was superior to 2-D ultrasonography in calculating the volume of adenomas with an estimated error not more than ±6% with regard to an estimated error not more than ±18% for 2- D TRUS. 3-D ultrasound showed excellent delineation of the transitional zone, especially in the coronal plane, which is the blind plane for 2-D ultrasonography.

In patients with prostatitis the combination of color Doppler U/S and 2D ultrasonography or 3D ultrasonography if possible gives better results than either method alone. Color Doppler U/S helps in identifying the hyperaemic prostatic foci and we suggest that the presence of peri-urethral zone of hyperaemia and irregular lucency is the most valuable sign for the inflammatory group (seen in all of our patients) as well as the presence of congested peri prostatic venous plexus.

Cases Presentation

1.1ANAT

1.3ANAT

P.C

Cancer prostate

Prostate Cancer -Capsular breaks

Capsular breaks

Periprostatic fat planes infiltration

Prostate cancer

Periprostatic fat planes infiltration

Prostate cancer

Periprostatic fat planes infiltration

BPH with associated extra capsular extension of PC

Prostate cancer infiltrating the urinary bladder

C.B

BPH

PROSTATIS

Prostatitis

Conclusion

3D TRUS and power Doppler sonography had increased the sensitivity, specificity and total accuracy of ultrasound In localizing the prostate cancer and in evaluating the capsular penetration and extracapsular spread of prostatic carcinomas. 3D TRUS offers more accurate volume estimation of prostatic adenomas and post-micturation residual urine.

Thank you